Covidien Device Sales Grow 10% In Q4, But Respiratory Still Faces Headwinds
This article was originally published in The Gray Sheet
Executive Summary
Covidien's sales of laparoscopic instruments, mesh hernia repair and vessel sealing products helped drive 10% growth in the diversified firm's device business to $1.7 billion in its fiscal fourth quarter, the firm reported Nov. 17